Counsyl, a startup that’s reinventing the modern clinical lab through robotics and custom software, today announced the launch of a new screening test that checks for inherited cancer risks. The company is also kicking off its Counsyl Complete platform for sharing test results between doctors and patients. Through its automated lab, Counsyl offers a faster screening process at a fraction of the cost. Insured patients can expect to pay between $150-$300 out of pocket on average for an inherited cancer screening, potentially saving as much as 70 percent from competing services. Counsyl promises to deliver its test results in two...
This story continues at The Next Web
from The Next Web http://ift.tt/1irritm
via IFTTT
Posts
0 Kommentare:
Kommentar veröffentlichen